Clinical Trial Update: Cediranib Maleate in Treating Patients With Malignant Mesothelioma That Cannot Be Removed By Surgery [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating cediranib maleate in patients with malignant mesothelioma that cannot be removed by surgery; the study is completed and result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Mesothelioma

Drugs mentioned

• Cediranib (Cediranib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Advanced Malignant Mesothelioma, Epithelial Mesothelioma | Phase 2 | Status: COMPLETED | Results posted: 2013-09-10